LGVN SHAREHOLDER LAWSUIT DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against the Longeveron Inc.Newsfile Corp • 09/21/21
Longeveron Announces Dr. Jorge Ruiz as Speaker for Roundtable Discussion & Presentation at 2021 International Conference for Frailty & Sarcopenia ResearchGlobeNewsWire • 09/21/21
LGVN Investor Alert: Rosen, Global Investor Counsel, Encourages Longeveron Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - LGVNNewsfile Corp • 09/19/21
LGVN Investor News: Rosen, Top Ranked Investor Counsel, Encourages Longeveron Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - LGVNPRNewsWire • 09/19/21
LONGEVERON ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Longeveron Inc. and Encourages Investors to Contact the FirmBusiness Wire • 09/17/21
SHAREHOLDER ALERT: Robbins LLP Announces that Longeveron Inc. (LGVN) is Being Sued for Misleading ShareholdersBusiness Wire • 09/17/21
LGVN Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Longeveron Inc. Investors of Class Action and Encourages Investors to Contact the FirmPRNewsWire • 09/17/21
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmPRNewsWire • 09/16/21
LGVN INVESTOR LAWSUIT DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against the Longeveron Inc.Newsfile Corp • 09/16/21
LGVN SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against the Longeveron Inc.PRNewsWire • 09/15/21
Heart Hope: Announcing the Encouraging Results of a Cell-Therapy Clinical Study by LongeveronBenzinga • 09/15/21
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 09/15/21
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 09/14/21
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Longeveron Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – LGVNBusiness Wire • 09/14/21
Pomerantz Law Firm Announces the Filing of a Class Action Against Longeveron Inc. and Certain Officers - LGVNPRNewsWire • 09/14/21
Longeveron Partners with Kinesiometrics to Create and Implement Cutting-Edge Smart Phone App to Measure Physical Responses to Cell TherapyGlobeNewsWire • 09/13/21
Longeveron Announces Final Results of Phase 1 Clinical Study of Lomecel-B Injection in Hypoplastic Left Heart Syndrome PatientsBenzinga • 09/09/21
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Longeveron Inc. - LGVNNewsfile Corp • 08/17/21
Longeveron's (LGVN) CEO Geoff Green on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/14/21
Longeveron Spikes As Lead Drug Produces Dose-Dependent Response In Aging Frailty Study; Primary Endpoint Not MetBenzinga • 08/13/21
Longeveron Inc. Provides Corporate Update and Reports Second Quarter 2021 Financial ResultsGlobeNewsWire • 08/13/21
Longeveron Announces Topline Results of Phase 2b Study of Lomecel-B for Aging FrailtyGlobeNewsWire • 08/13/21
